Fact CheckerSign in

NCT04970888Recruiting

Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure

Source: ClinicalTrials.gov · Last updated 2 Dec 2025

Brief summary (registry, in English)

The objective of this project is to assess the effects of combined physical exercise and cognitive training interventions on cognitive and brain health in patients with heart failure (HF). Also, the role of sex on the effects of the interventions will be assessed.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
216 (estimated)
First submitted
12 Jul 2021
Start date
1 Sept 2021
Primary completion date
1 Dec 2026
Lead sponsor
Montreal Heart Institute
NCT number
NCT04970888

What you commit to

  • Study type: Interventional
  • Planned participants: 216
  • From 1 Sept 2021 to the primary completion date, 1 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Acute cardiovascular event 1 month prior to randomization, including emergency visit or hospitalization for decompensated HF, acute myocardial infarction, stroke, and transient ischemic attack

Other illness

  • Planned cardiovascular intervention within 6 months (implantation of any cardiac device, cardiac revascularization, heart transplantation)
  • Contraindications for exercise testing (e.g., uncorrected severe aortic or carotid stenosis, severe pulmonary hypertension, severe non-revascularizable coronary disease including left main coronary stenosis, significant myocardial ischemia or arrhythmia during low-intensity exercise, acute HF)
  • Severe respiratory disease
  • Non-cardiopulmonary limitation to exercise (e.g., arthritis, claudication or any peripheral neurological disease including other neurodegenerative diseases such as disabling Parkinson)
  • Uncontrolled diabetes or untreated thyroid dysfunction
  • Current or recent malignancy with life expectancy \< 1 year

Other

  • Severe exercise intolerance
  • Chronic hemodialysis or peritoneal dialysis
  • Unable to read the informed consent form or unable to understand the oral explanations provided by the assessor.

Who the study is looking for

  • Age ≥ 50 years old
  • Stable chronic HF on maximally tolerated background treatment for at least 2 months (stable therapy with ACE-I, ARBs and MRA for at least 2 months), regardless of LVEF
  • with no limitation of physical activity in ordinary physical activity (i.e. NYHA class I), moderate symptoms (i.e. NYHA class II) or marked limitation in activity (i.e. NYHA class III)
  • Able to perform cognitive and physical training.

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Preventive medicine and physical activity centre (centre EPIC), Montreal Heart Institute
Coordinator of this site? Confirm its status
MontrealCanadaRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.